Reliability and Validity of SARC-F Questionnaire to Assess Sarcopenia Among Vietnamese Geriatric Patients

Autor: Nguyen TN, Nguyen AT, Khuong LQ, Nguyen TX, Nguyen HTT, Nguyen TTH, Hoang MV, Pham T, Vu HTT
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Clinical Interventions in Aging, Vol Volume 15, Pp 879-886 (2020)
Druh dokumentu: article
ISSN: 1178-1998
Popis: Tam Ngoc Nguyen,1,2 Anh Trung Nguyen,1,2 Long Quynh Khuong,3 Thanh Xuan Nguyen,1,2 Huong Thi Thu Nguyen,1,2 Thu Thi Hoai Nguyen,1,2,4 Minh Van Hoang,3 Thang Pham,1,2 Tu Ngoc Nguyen,5 Huyen Thi Thanh Vu1,6 1Department of Geriatrics, Hanoi Medical University, Hanoi, Vietnam; 2Scientific Research Department, National Geriatric Hospital, Hanoi, Vietnam; 3Hanoi University of Public Health, Hanoi, Vietnam; 4Dinh Tien Hoang Institute of Medicine, Hanoi, Vietnam; 5Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; 6Hanoi Medical University Hospital, Hanoi, VietnamCorrespondence: Huyen Thi Thanh VuDepartment of Geriatrics, Hanoi Medical University, 01 Ton That Tung, Dong Da, Hanoi, VietnamTel +84913531579Email vuthanhhuyen11@hmu.edu.vnBackground: The SARC-F questionnaire has been developed as a rapid diagnostic test that can be used to screen for sarcopenia.Aim: To investigate the reliability and validity of the Vietnamese version of SARC-F as a screening tool for sarcopenia in older patients in Vietnam.Methods: A cross-sectional study was conducted in older people attending the outpatient clinics of the National Geriatric Hospital in Vietnam. Muscle mass (using dual-energy X-ray absorptiometry), handgrip strength and gait speed were assessed. SARC-F was validated against the three standard criteria for sarcopenia: the Foundation for the National Institutes of Health (FNIH), Asia Working Group for Sarcopenia (AWGS 2019) and European Working Group on Sarcopenia in Older People (EWGSOP2).Results: There were 764 participants (mean age 71.5 ± 8.9 years). The Vietnamese SARC-F questionnaire had a good internal consistency (Cronbach’s alpha 0.85). The prevalence of sarcopenia was 49.2% according to SARC-F and 48.3%, 61.1% and 52.6% according to FNIH, AWGS 2019 and EWGSOP2, respectively. The sensitivity and specificity of SARC-F in identifying sarcopenia were 67.1% and 66.7% (for FINH), 66.7% and 67.1% (for AWGS 2019), and 64.9% and 68.2% (for EWGSOP2). The AUCs of SARC-F were 0.71– 0.72 against the three sarcopenia criteria.Conclusion: The Vietnamese version of SARC-F questionnaire has acceptable diagnostic value for sarcopenia. SARC-F could be used as an initial screening for sarcopenia in hospital clinics.Keywords: older patients, sarcopenia, SARC-F, Vietnam
Databáze: Directory of Open Access Journals